What is DA Davidson’s Estimate for NUS FY2024 Earnings?

Nu Skin Enterprises, Inc. (NYSE:NUS) – Investment analysts at DA Davidson boosted their FY2024 EPS estimates for Nu Skin Enterprises in a report issued on Thursday, February 13th. DA Davidson analyst C. Xue now expects that the company will earn $0.67 per share for the year, up from their prior forecast of $0.66. DA Davidson has a “Neutral” rating and a $7.00 price objective on the stock. The consensus estimate for Nu Skin Enterprises’ current full-year earnings is $0.68 per share. DA Davidson also issued estimates for Nu Skin Enterprises’ Q4 2024 earnings at $0.21 EPS.

Nu Skin Enterprises (NYSE:NUS) last announced its quarterly earnings data on Thursday, February 13th. The company reported $0.38 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $0.24 by $0.14. Nu Skin Enterprises had a negative net margin of 5.81% and a positive return on equity of 5.47%.

A number of other equities research analysts also recently issued reports on NUS. Citigroup reduced their price objective on shares of Nu Skin Enterprises from $11.50 to $6.75 and set a “neutral” rating on the stock in a research note on Tuesday, October 22nd. StockNews.com upgraded shares of Nu Skin Enterprises from a “hold” rating to a “buy” rating in a report on Monday, November 11th.

Nu Skin Enterprises Stock Up 1.3 %

Shares of Nu Skin Enterprises stock opened at $6.41 on Friday. The company has a current ratio of 1.93, a quick ratio of 1.20 and a debt-to-equity ratio of 0.53. Nu Skin Enterprises has a 12-month low of $5.95 and a 12-month high of $17.68. The firm’s 50-day moving average price is $6.91 and its two-hundred day moving average price is $7.50.

Institutional Inflows and Outflows

Hedge funds have recently added to or reduced their stakes in the company. Weiss Asset Management LP bought a new position in Nu Skin Enterprises during the 3rd quarter worth approximately $2,727,000. Centiva Capital LP acquired a new stake in shares of Nu Skin Enterprises during the 3rd quarter worth approximately $508,000. Verition Fund Management LLC acquired a new stake in shares of Nu Skin Enterprises during the 3rd quarter worth approximately $581,000. JPMorgan Chase & Co. grew its position in shares of Nu Skin Enterprises by 175.6% during the 3rd quarter. JPMorgan Chase & Co. now owns 231,957 shares of the company’s stock worth $1,710,000 after buying an additional 147,784 shares during the period. Finally, Hotchkis & Wiley Capital Management LLC grew its position in shares of Nu Skin Enterprises by 27.7% during the 3rd quarter. Hotchkis & Wiley Capital Management LLC now owns 603,555 shares of the company’s stock worth $4,448,000 after buying an additional 130,980 shares during the period. Institutional investors own 82.84% of the company’s stock.

About Nu Skin Enterprises

Nu Skin Enterprises, Inc, together with its subsidiaries, engages in the development and distribution of various beauty and wellness products worldwide. It offers skin care devices, cosmetics, and other personal care products, including ageLOC LumiSpa and ageLOC LumiSpa iO; and nutricentials skin care products.